A Study to Determine Appropriate Dosage for Vapor Therapy and Other Ablative Therapies to Treat Cancerous Prostate and Kidney Tissue


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 13-004645
    Sponsor Protocol Number: 1924-001

About this study

The study objectives are to determine the appropriate dosage for vapor therapy and other ablative therapies to treat cancerous prostate and kidney tissue.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Subjects with the ability to understand and consent to releasing their extirpated prostate or kidney for use in this study, if required by the site.

Prostate Tissue:

  • Prostates with a confirmed biopsy demonstrating adenocarcinoma removed via a radical prostatectomy.
  • Prostates with biopsy confirmed recurrent adenocarcinoma removed via a salvage radical prostatectomy.
  • Prostates with or without cancer that have been removed via a radical cystoprostatectomy or pelvic exenteration.

Kidney Tissue:

  • Kidneys removed via a total or partial nephrectomy – no enucleations will be used.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lance Mynderse, M.D.

Contact us for the latest status

Contact information:

Lance Mynderse M.D.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions